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Comparison of the diagnosis of leukaemia from death
certificates, cancer registration and histological reports-
implications for occupational case-control studies
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Summary It is essential in occupational case-control studies of rare diseases for ascertainment to be as complete as possible, togetherwith
an accurately defined diagnosis. A nested case-control study from a large cohort of UK oil distribution workers followed up since 1950 was
carried out to investigate the association between leukaemia, in particular acute myeloid leukaemia, and exposure to benzene. Ninety-one
cases occurring before 1993 were identified from death certificates or cancer registrations (available from 1971). Histopathology departments
were contacted to obtain material that might confirm the diagnosis of leukaemia and this was received for 39 (43%) cases. The majority of the
cases (88) were identified primarily from death certificates, with a cancer registration also being received for 56 (90%) of the 62 deaths
occurring after 1971. Discrepancies in the diagnoses from these two sources were found for 12 cases, five being acute myeloid leukaemia.
For the majority, the diagnosis on the death certificate was more specific than that on the cancer registration. Histology reports were received
for nine ofthe discrepancies, all confirming the death certificate diagnosis. Although leukaemia appears to be regularly registered as acancer,
records may not be routinely updated when new clinical information becomes available. It is recommended that death certificates, cancer
registrations and histology reports are obtained routinely by cancer registries to maximize both numbers of cases and diagnostic accuracy for
epidemiological studies.
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For case-control studies in which the disease under investigation
is a rare one, it is essential that not only as many cases as
possible are identified, but that the diagnosis ofthe disease should
be accurately defined. This paper presents the results ofa compar-
ison ofthe diagnosis ofleukaemias from death certificates, cancer
registrations and histological reports, and discusses the implica-
tions for a study of oil distribution workers, investigating the
possible association between leukaemia and exposure to low
levels ofbenzene.
The National Health Service Central Register (NHSCR) at
Southport, UK, provides the means whereby researchers can
obtain both the death details and the cancer registrations of study
populations. The provision of death certificates is a straight-
forward process, with death notifications (death registration is
mandatory) being linked to the NHSCR records and hence avail-
able to the researcher. Cancer registration, on the other hand, is a
non-statutory process, being administered by regional cancer
registries which differ in their methods of data collection
(Alderson, 1988). Figure 1 illustrates the process by which a
researcher receives notification of cancer registrations, and the
stages at which incompleteness may occur.
The regional registries have been shown to vary in the
completeness and accuracy oftheir data (Swerdlow, 1986; OPCS,
1987; Silcocks et al, 1989; Kardara et al, 1995). Completeness of
flagging of registrations by NHSCR, the process linking cancer
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registration records with the National Health Service records, is
important for research studies. The proportion of cancer registra-
tions received by the Office of Population Censuses and Surveys
(OPCS) which were successfully linked to a NHSCR record
appears to have been about 96% (Swerdlow, 1986). Several
studies have investigated the completeness and accuracy of inci-
dence information for leukaemias and other related neoplasms.
Kemp et al (1980) suggested that a rise in the incidence of acute
myeloid leukaemia between 1968-72 and 1973-77, shown in
Scottish cancer registration data, was partly because of better
diagnosis and partly because of a real increase, but not because
of an improvement in registration. Bowie (1987) compared 327
leukaemia cases on the South West Cancer Registry during 1971
and 1984 with 307 patients on a local case register from the
haematology department of a district general hospital. The two
lists together identified 418 individual cases. There were 209
patients common to both lists, with 111 (27%) occurring only on
the local register and 98 (23%) occurring only on the regional
registry. These figures varied by year of diagnosis and type of
leukaemia. They point out that chronic lymphocytic leukaemia
cases, which are often treated as outpatient cases, may be less
often registered with the regional cancer registry. Alexander and
her colleagues (1989) compared the Leukaemia Research Fund
(LRF) centre registry ofhaematopoietic malignancies with notifi-
cations from three cancerregistries. Of 1792 notifications received
from the three cancer registries, 1296 (72%) had been registered
independently by the LRF and 236 (13%) ledto new LRFnotifica-
tions. The remaining 260 included 111 for whom case notes
confirmed that there was no relevant malignancy and 73 for whom
records could not be traced. The LRF were aware ofan additional
1268 cases, not registered by the three cancer registries.













Incompleteness can occur at four crucial stages of the process
Voluntary process
Varying data collection methods
Changes in diagnostic practice
Misclassification of a cancer





Figure 1 Cancer registration process from 1971
Table 1 Numbers of cases and source of identification by type of leukaemia
Leukaemia type Identified from death certificates Additional from Total
cancer notification
Underlying cause Contributory cause
Acute lymphatic 7 7
Chronic lymphatic 22 8 1 31
Other lymphatic 1 1
Acute myeloid 30 1 31
Chronic myeloid 8 3 11
Other myeloid 1 1 2
All monocytic 3 3
All other 4 1 5
All leukaemia 75 13 3 91
METHOD
A cohort of approximately 23 300 men from UK oil distribution
centres has been followed up since 1950. To be eligible for the
cohort the men had to have worked for at least 1 year between
1950 and 1975. Results for mortality have been published for two
follow-up periods, the first to 1975 (Rushton and Alderson, 1983)
and the second to 1989 (Rushton, 1993). In the second follow-up
some excess mortality was found from leukaemia, in particular
acute myeloid leukaemia, which has been associated in other
studies with possible exposure to benzene (Vigliani, 1976; Brandt
et al, 1978; Aksoy, 1989), a constituent of some oil products, such
as motor gasoline. The standardized mortality ratio for the total
distribution centre population for all leukaemias was 108 [95%
confidence interval (CI) 83-140] and for acute myeloid leukaemia
was 121 (95% CI 78-179). For those whose last job title was
driver, the corresponding figures were 125 (95% CI 83-181) and
155 (95% CI 82-265). Anestedcase-control study was carried out
during 1993-95 to investigate these findings. The method of
developing quantitative exposure estimates of benzene and the
results of the study are published elsewhere (Rushton and
Romaniuk, 1997; Lewis et al, 1997). Cases were defined as those
who (1) died before 1 January 1993 with a mention (either under-
lying or contributory cause) ofleukaemia (ICD 9th revision codes
204-208) on the death certificate or (2) had a cancer registration
(only available from 1971 onwards) of leukaemia (ICD 9th revi-
sion codes 204-208) with a diagnosis date before 1 January 1993.
Permission to contact histopathology departments to ask for
histological confirmation of the diagnoses was obtained from
OPCS. The majority of the cases were identified from death
certificates and, even by the end ofthe study in December 1995, a
large number of the cancer registrations for these deaths had not
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Table 2 Cases identified from death certificates - numbers of histological confirmations and cancer registrations received
Pre-cancer registration before 1971 Post-cancer registration 1971 and after
Leukaemia type Death certificates Histological Death certificates Histological Cancer registration
information received Information received received
Acute lymphatic 2 1 5 4 5
Chronic lymphatic 8 4 22 12 19
Acute myeloid 7 23 10 21
Chronic myeloid 3 8 5 7
Other 6 4 3 4
Total 26 5 62 34 56
Table 3 Inconsistencies between diagnoses from death certificates and cancer registrations
Death certificate Cancer registration Histology confirms
death certificate
Cause Year of death Cause Year of diagnosis
Acute lymphatic 1982 Other leukaemia 1982 Yes
Acute lymphatic 1989 Other lymphatic 1989 Yes
Chronic lymphatic 1981 Other lymphatic 1979 Yes
Chronic lymphatic 1981 Other lymphatic 1978 Yes
Chronic lymphatic 1989 Other lymphoma 1982 Yes
Acute myeloid 1973 Chronic myeloid 1970 Unavailable
Acute myeloid 1979 Acute monocytic 1978 Unavailable
Acute myeloid 1984 Acute monocytic 1984 Yes
Acute myeloid 1986 Other myeloid 1986 Unavailable
Acute myeloid 1989 Other neoplasm of lymphatic tissue 1987 Yes
Acute unspecified 1982 Acute erythraemia and erythroleukaemia 1982 Yes
Acute unspecified 1986 Unspecified leukaemia 1982 Yes
yet been received. The death certificate was thus generally the
main source of information as to the hospital or area where the
leukaemia might have been diagnosed and hence where the
histology records might be held. The process of obtaining
histology records was therefore sometimes lengthy and involved
writing to severalhospitals. A standard proformagiving identifica-
tion details, place and date of death, date of diagnosis if known,
diagnoses on the death certificate and/or cancer registration was
sent to each hospital, together with a standard letter outlining the
purpose of the study and prepaid return envelope. Hospitals were
also asked for copies of any reports on bone marrow, blood films,
histology or pathology. Copies were often retumed with the
proformas and, for a few cases, specimen slides or patient notes
were sent. Slides were sentto thepathology department atQueen's
Medical Centre for examination. Reminder letters were sent, or
telephone calls were made, to the hospitals to try and improve the
response rate.
RESULTS
Ninety-one cases ofleukaemia were identified in the cohort. Table
1 gives the numbers by type ofleukaemia and source ofidentifica-
tion. The largest groups were chronic lymphatic leukaemia and
acute myeloid leukaemia, each with 31 cases. Ofthe 88 cases iden-
tified from death certificates, 75 (85%) were the underlying cause
of death, including all the acute leukaemias. In contrast, 11 of the
13 cases identified as a contributory cause of death were chronic
leukaemias. The underlying causes of death for these 13
leukaemias were heart disease (six), stroke (two), pneumonia
(two), cancer of the pancreas (one), chronic obstructive airway
disease (one) and hyperplasia of the prostate (one). Three cases
were identified solely from cancer registration records. All had
died but leukaemia was not mentioned on the death certificate,
the underlying causes being an occurrence of ruptured aortic
aneurysm, unspecified neoplasm of the lymphatic and haemato-
poietic tissue andunspecified cancer ofthe bronchus and lung.
Confirmation ofthe diagnosis was received for 39 (43%) ofthe
cases. In the majority of these, copies of the relevant reports,
histology, post-mortem and/or haematology were sent. No
histology report orotherpatientrecord couldbe found fora further
36 (40%). Many of the hospitals contacted about these reported
that early records had been destroyed. This group also included
two early cases for whom place of death was not stated on the
death details received from OPCS. For one further case a confir-
mation of a bladder cancer was received but the notes did not
confirm the leukaemia. No reply from any of the hospitals
contacted was received for the remaining 15 (16%) cases.
Histological information was not obtained for the three cases
identified solely from cancer registration. Table 2 gives, for the 88
cases identified from death certificates, the numbers for which
histological information was received by leukaemia subtype.
Information was received for about half of the cases occurring
after 1971, but for only five (19%) before that date.
Cancerregistrations werereceived for56 (90%) ofthe 62 deaths
occurring after 1971. These are also shown in Table 2. A cancer
registration was received for another type ofcancer for two ofthe
six for whom a leukaemia registration had not been received. For
two others, OPCS discovered that they had never actually been
registered with the appropriate regional registry. They also identi-
fied fourcases that had been registered with a regional registry but
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their details had failed to be flagged. In both situations the appro-
priate registrations have now been made.
The five histology reports received for deaths before 1971 all
confimned the diagnosis on the death certificate. However, there
were discrepancies between the death certificate and the cancer
registration diagnoses in 12 of the 56 cases occurring after 1971
for whom both records existed. Table 3 gives the diagnostic details
of these 12 cases, together with the years of death and diagnosis
and whetherhistological confirmation ofthe deathcertificate diag-
nosis was obtained. Histology reports were obtained for nine of
these discrepancies, all of them confirming the diagnosis on the
death certificate. It can be seen that in nine cases the diagnosis
fromthe cancerregistration was less specific than thaton the death
certificate, for example unspecified lymphatic rather than acute or
chronic lymphatic. Two ofthe acute myeloid leukaemias had been
coded as acute monocytic leukaemia on the cancer registration.
These two types of leukaemia are probably similar in aetiology
(Linet, 1985) and in fact were combined in the case-control
analysis.
In addition to those detailed in Table 3, there was one case for
which both the death certificate and cancer registration gave
unspecified myeloid leukaemia as the diagnosis, but a marrow
report suggested 'the features are those of chronic myelomono-
cytic leukaemia'.
DISCUSSION
The process of flagging a large occupational cohort, such as this
group of oil distribution workers, to obtain death certificates and
cancer registrations can be lengthy and complex. During the years
this cohort has been followed up, the NHSCR has seen several
major changes and developments to its systems. In spite of the
various potential sources of error, this small study has shown that
when leukaemia is mentioned on a death certificate the flagging
process identifies most leukaemia registrations, although this can
take several years. This study was not designed to ascertain
whether all possible leukaemia cases had been identified from
either death certificates or cancer registrations. However, an acute
leukaemia is more likely to be mentioned on a death certificate
than a chronic leukaemia and, in fact, all but one of the acute
leukaemias in this study were the underlying cause ofdeath.
It is not known in this study how many of the cancers were
registered from death certificates. The average number of years
between a cancerregistration and death was 1.8 years. This varied
by diagnosis, for example with 57% of the acute myeloid
leukaemias having the same year ofdiagnosis and death and 24%
having only 1 yeardifference (overall average0.8 years). This is in
contrast to chronic lymphatic leukaemia, which had 47% with a
difference ofover 4 years (overall average 3.7 years).
Obtaining cancer registrations in addition to death certificates
enables case-control studies tobe carried out with incidentcases as
the event, rather than death. In addition, terminating the duration of
exposure at death rather than at diagnosis, particularly if death
occurs while the case is still in employment, may lead to an overes-
timation ofthe relevant exposure to the hazard under investigation.
Comparison of the diagnoses obtained from death certificates
and cancer registrations identified several discrepancies, with a
general tendency for the histology to confirm the diagnosis on the
death certificate. In many instances, this was the more specific
diagnosis. This indicates that, although leukaemia may be regis-
tered at an early stage, the registration may not be updated after
investigations have established the specific type ofleukaemia.This
may occur because (a) the new information is not given to the
registry or (b) a system may not be in place at the registries to
routinely search forchanges in previously received diagnoses.
The implications of non-identification of cases and misclassi-
fication of diagnosis for this type of occupational study are
potentially serious. Previous studies investigating the possible
association of leukaemia with exposure to benzene have had only
small numbers of cases (Bond et al, 1986; Rinsky et al, 1987;
Schnatter et al, 1996). The current study, with relatively large
numbers, had the potential to increase the precision of previous
risk estimates. It was also important to obtain a correct diagnosis
so that leukaemic subtype analyses could be carried out, particu-
larly for acute myeloid leukaemia, the subtype particularly associ-
ated in previous studies with exposure to benzene (Aksoy, 1988;
McMichael, 1988; Wong, 1995).
There were difficulties inobtaining thehistological information,
with a disappointingly low number of histology reports received.
Identification of the hospitals at which the diagnosis was made
was not straightforward, particularly for those who had died at
home and for those for whom a cancer registration was not avail-
able. Many hospitals did notkeep theirrecords as farback as 1951,
hence the low response for deaths before 1971. There were also
several refusals from hospitals to examine records, the main
reasons given being lack ofstaffand pressure ofwork.
This study, although small, has shown the importance in nested
case-control studies of rare diseases of using both death certifi-
cates and cancer registrations for identification of the maximum
number of cases. It has also demonstrated the usefulness of
obtaining histological records to confirm the diagnosis and to
resolve any discrepancies between death certificates and registra-
tion. The study identified several areas of incompleteness in the
cancer registration system, the most important being the lack of
updating of records when new information on the diagnosis had
become available. Many regional cancer registries do routinely
update their records as they become aware ofcorrections or addi-
tions to theirdata, and these amendments should also be passed on
to OPCS. However, it is not clear how many seemingly minor
updates, for example involving the fourth digit of the ICD code,
are transmitted. For many disease groups, this may not be impor-
tant. For diseases, such as leukaemia, for which the fourth digit
indicates very different diseases with different aetiologies, treat-
ment and prognosis (Linet, 1985), this level of accuracy is desir-
able. Future comparative analyses of the diagnoses on the death
certificates and cancer registrations for other cancers in the cohort
of oil distribution centre workers may provide further insight into
other areas of potential discrepancy. The cancer registration
system would benefit from the establishment of a registry-wide
procedure for ensuring that registrations are updated when new
diagnostic information becomes available. Some cancer registries
already use histopathology reports as a source ofboth notification
and confirmation of the diagnosis. As the majority ofcancers will
have some form of histopathology report, all cancer registries
should be encouraged to use these.
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